Karo Pharma AB buy Morgan Stanley
Start price
24.07.23
/
50%
€5.44
Target price
24.07.24
€30.66
Performance (%)
-
End price
25.07.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Karo Pharma AB | - | - | - |
iShares Core DAX® | 3.523% | 3.763% | 26.705% |
iShares Nasdaq 100 | 1.026% | 2.380% | 29.587% |
iShares Nikkei 225® | -0.063% | 0.000% | 15.214% |
iShares S&P 500 | 0.557% | 2.222% | 27.662% |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $37.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten